|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_ocn754765304 |
003 |
OCoLC |
005 |
20231117044611.0 |
006 |
m o d |
007 |
cr mnu---unuuu |
008 |
110927s2011 ne a ob 000 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d IDEBK
|d OPELS
|d E7B
|d BTCTA
|d YDXCP
|d BWX
|d OSU
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d CHVBK
|d OCLCQ
|d OCLCF
|d NLGGC
|d OCLCQ
|d LVT
|d OCLCQ
|d ESU
|d U3W
|d D6H
|d OCLCO
|d AU@
|d OCLCO
|d FEM
|d CASUM
|d WYU
|d OCLCO
|d LEAUB
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 707329349
|a 742299100
|a 969034839
|a 1058062017
|a 1082208671
|
020 |
|
|
|a 9780123878205
|q (electronic bk.)
|
020 |
|
|
|a 0123878209
|q (electronic bk.)
|
020 |
|
|
|z 9780123878199
|
020 |
|
|
|z 0123878195
|
020 |
|
|
|a 9786613171320
|
020 |
|
|
|a 6613171328
|
035 |
|
|
|a (OCoLC)754765304
|z (OCoLC)707329349
|z (OCoLC)742299100
|z (OCoLC)969034839
|z (OCoLC)1058062017
|z (OCoLC)1082208671
|
050 |
|
4 |
|a QP552.G76
|b S54 2011eb
|
060 |
|
4 |
|a QU 55.2
|b .S551g 2011
|
072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99406
|2 22
|
100 |
1 |
|
|a Sherbet, G. V.
|q (Gajanan V.)
|
245 |
1 |
0 |
|a Growth factors and their receptors in cell differentiation, cancer and cancer therapy /
|c G.V. Sherbet.
|
250 |
|
|
|a 1st ed.
|
260 |
|
|
|a Amsterdam ;
|a Boston :
|b Elsevier,
|c 2011.
|
300 |
|
|
|a 1 online resource (xix, 347 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|2 rda
|
490 |
1 |
|
|a Elsevier insights
|
520 |
|
|
|a Recent years have seen a considerable emphasis on growth factors and the elucidation of their mode of function, which has led to the recognition that growth factors, their receptors as well as downstream elements of signalling associated with their function might be potential targets in therapeutic management of human diseases. Humanised monoclonal antibodies raised against growth factor receptors have proved to be valuable for targeted cancer treatment and in patient management. This book reviews the latest developments providing insights into the signalling processes involved in morphogenesis and pathogenesis with emphasis on using the elements of the signalling cascades as targets for therapeutic deployment. Provides a fundamental understanding of the basic functions of growth factors and their receptors, describing how they are linked in biological processes. Aids the development of therapeutic treatments for cancer. Focuses on the interrelationships and convergence of growth factors and their receptors in development and pathogenesis and encourages greater cooperation and integration in the areas of developmental, cancer and cancer therapeutic research.
|
504 |
|
|
|a Includes bibliographical references (pages 249-347).
|
505 |
0 |
|
|a Convergence of growth-factor signalling pathways in developmental systems and pathogenesis -- Growth factor families -- Growth factors in differentiation and morphogenesis -- Vascular endothelial growth factor -- Hepatocyte growth factor -- Platelet-derived growth factor family -- Nerve growth factors -- Insulin-like growth factors -- Connective tissue growth factors -- Thrombospondins -- Cytokines -- Growth factor and hedgehog signalling pathways meet in developmental systems -- Epidermal growth factors and their signalling systems -- Epidermal growth factor (EFG) family -- Fibroblast growth factor family -- Intracellular receptor building growth factors -- Androgens and androgen receptors in development, differentiation and neoplasia -- Vitamin D₃ in cell proliferation, apoptosis and differentiation -- Retinoids in development and pattern formation -- Oestrogens and progesterone in normal physiology and neoplasia -- Glucocorticoid signalling in normal and aberrant physiology.
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Growth factors
|x Therapeutic use.
|
650 |
|
0 |
|a Cancer
|x Treatment.
|
650 |
|
0 |
|a Cellular therapy.
|
650 |
|
0 |
|a Cell differentiation.
|
650 |
|
0 |
|a Cells
|x Growth.
|
650 |
|
0 |
|a Metastasis.
|
650 |
1 |
2 |
|a Intercellular Signaling Peptides and Proteins
|x metabolism
|0 (DNLM)D036341Q000378
|
650 |
1 |
2 |
|a Receptors, Growth Factor
|x metabolism
|0 (DNLM)D017978Q000378
|
650 |
2 |
2 |
|a Cell Differentiation
|0 (DNLM)D002454
|
650 |
2 |
2 |
|a Neoplasms
|x etiology
|0 (DNLM)D009369Q000209
|
650 |
2 |
2 |
|a Neoplasms
|x therapy
|0 (DNLM)D009369Q000628
|
650 |
|
2 |
|a Cell- and Tissue-Based Therapy
|0 (DNLM)D064987
|
650 |
|
2 |
|a Neoplasm Metastasis
|0 (DNLM)D009362
|
650 |
|
6 |
|a Facteurs de croissance
|0 (CaQQLa)201-0012819
|x Emploi en th�erapeutique.
|0 (CaQQLa)201-0373975
|
650 |
|
6 |
|a Cancer
|x Traitement.
|0 (CaQQLa)201-0004693
|
650 |
|
6 |
|a Th�erapie cellulaire.
|0 (CaQQLa)201-0060280
|
650 |
|
6 |
|a Cellules
|x Diff�erenciation.
|0 (CaQQLa)201-0030846
|
650 |
|
6 |
|a Cellules
|x Croissance.
|0 (CaQQLa)201-0062119
|
650 |
|
6 |
|a M�etastases.
|0 (CaQQLa)201-0043239
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|0 (OCoLC)fst00845538
|
650 |
|
7 |
|a Cell differentiation
|2 fast
|0 (OCoLC)fst00850182
|
650 |
|
7 |
|a Cells
|x Growth
|2 fast
|0 (OCoLC)fst00850262
|
650 |
|
7 |
|a Cellular therapy
|2 fast
|0 (OCoLC)fst00850322
|
650 |
|
7 |
|a Growth factors
|x Therapeutic use
|2 fast
|0 (OCoLC)fst00948613
|
650 |
|
7 |
|a Metastasis
|2 fast
|0 (OCoLC)fst01018329
|
655 |
|
4 |
|a Internet Resources.
|
776 |
0 |
8 |
|i Print version:
|a Sherbet, G.V. (Gajanan V.).
|t Growth factors and their receptors in cell differentiation, cancer and cancer therapy.
|b 1st ed.
|d Amsterdam ; Boston : Elsevier, 2011
|z 9780123878199
|w (OCoLC)751833990
|
830 |
|
0 |
|a Elsevier insights.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123878199
|z Texto completo
|